Hereditary haemolytic anaemias represent the most prevalent group of genetic disorders worldwide and have a substantial impact on global health, according to new research published in The Lancet. These inherited blood disorders cause red blood cells to break down faster than normal, leading to anemia and other complications.
Current treatments for these conditions are limited and primarily supportive, leaving patients with few therapeutic options. The disorders affect millions of people globally, yet medical advances have been slow to address the underlying causes of these genetic conditions.